4//SEC Filing
Marriott Tina 4
Accession 0001601830-24-000068
CIK 0001601830other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 6:31 PM ET
Size
16.7 KB
Accession
0001601830-24-000068
Insider Transaction Report
Form 4
Larson Tina Marriott
President and COO
Transactions
- Exercise/Conversion
Class A Common Stock
2024-05-30$1.06/sh+3,000$3,180→ 538,457 total - Sale
Class A Common Stock
2024-05-30$8.78/sh−3,000$26,325→ 535,457 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-05-30−0→ 482,000 totalExercise: $1.06Exp: 2028-07-22→ Class A Common Stock (3,000 underlying)
Holdings
- 4,784
Stock Option (Right to Buy)
Exercise: $11.40From: 2022-02-04Exp: 2032-02-04→ Class A Common Stock (0 underlying) - 447,917
Stock Option (Right to Buy)
Exercise: $10.09Exp: 2034-02-09→ Class A Common Stock (0 underlying) - 150,000
Stock Option (Right to Buy)
Exercise: $2.48Exp: 2030-12-30→ Class A Common Stock (0 underlying) - 159,226
Stock Option (Right to Buy)
Exercise: $11.40Exp: 2032-02-04→ Class A Common Stock (0 underlying) - 434,122
Stock Option (Right to Buy)
Exercise: $8.55Exp: 2033-02-01→ Class A Common Stock (0 underlying)
Footnotes (8)
- [F1]Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person dated March 1, 2023.
- [F2]Includes 2,224 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2024.
- [F3]This transaction was executed in multiple trades at prices ranging from $8.65 to $8.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F4]Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date.
- [F5]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
- [F6]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
- [F7]One forty-eighth (1/48th) of the shares subject to the award shall vest one month after December 31, 2020, or the Monthly Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Monthly Vesting Commencement Date.
- [F8]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
Documents
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
Related Parties
1- filerCIK 0001856414
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 6:31 PM ET
- Size
- 16.7 KB